SEOUL, Dec. 1 (Korea Bizwire) — With the end of the coronavirus pandemic still a distant hope, a recent study has reported that 5 in 100 South Koreans are suffering from depression. A research team from Seoul’s Asan Medical Center said Monday the study results of a big data analysis of 1 million patients compiled [...]
SEOUL, Nov. 29 (Korea Bizwire) — The ruling Democratic Party has raised its coronavirus vaccine supply target to 44 million people, or 85 percent of the country’s population, a key party source said Sunday. The figure is sharply higher than the 30 million target previously cited by health authorities. To secure the vaccines, the party [...]
DAEJEON, Nov. 27 (Korea Bizwire) — A South Korean research team has developed a reverse-aging technology that can transform aged cells into young cells. A joint team consisting of researchers from the Korea Advanced Institute of Science and Technology and those from cosmetics giant Amorepacific Corp. said Thursday it had developed a reverse-aging technology that [...]
SEOUL, Nov. 25 (Korea Bizwire) — South Korea joined the Coalition for Epidemic Preparedness Initiative (CEPI) and pledged to donate US$3 million this year to help develop vaccines for COVID-19 and other emerging epidemics, the foreign ministry said Wednesday. The CEPI is a global partnership joined by public, private and civil society organizations to fund [...]
SEOUL, Nov. 24 (Korea Bizwire) – South Korea’s drug safety agency has approved clinical trials of vaccine and treatment candidates currently under development by two local drug manufacturers, industry officials said Tuesday. The Ministry of Food and Drug Safety on Monday gave the green light to conduct a phase one clinical trial of a vaccine [...]
SEOUL, Nov. 24 (Korea Bizwire) — The number of South Korean women who freeze their eggs for the chance to have a baby of their own later is increasing. Oocyte cryopreservation, more commonly known as egg freezing, is a method of preserving a woman’s fertility so she can try to have children at a later date. [...]
SEOUL, Nov. 20 (Korea Bizwire) — A recent study has found that a higher density of ultrafine dust in the atmosphere aggravates the symptoms of allergic rhinitis. A research team led by Hong Seung-no, a professor of otolaryngology at the Boramae Medical Center, said Thursday it confirmed the correlation between the density of ultra-fine dust [...]
SEOUL, Nov. 18 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc.’s coronavirus treatment is likely to file for emergency authorization use from local drug authorities next month, the company’s chief said Wednesday. CT-P59, anti-COVID-19 monoclonal antibody treatment, is currently undergoing a phase two clinical trial locally after successfully completing a phase one clinical trial [...]
SEOUL, Nov. 18 (Korea Bizwire) — A number of major South Korean pharmaceutical companies have recently signed a series of deals to manufacture vaccines and treatment drugs for the novel coronavirus, industry watchers said Wednesday. Among the front-runners is industry leader Samsung Biologics Co., which successfully inked two contract manufacturing organization (CMO) agreements this year. [...]
SEOUL, Nov. 17 (Korea Bizwire) — South Korean pharmaceutical firm Samsung Biologics Co. said Tuesday it has signed a long-term agreement with U.S. pharmaceutical firm Eli Lilly and Company to manufacture a novel coronavirus-neutralizing antibody. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will provide Eli Lilly’s investigational neutralizing antibody for the treatment of [...]